NCT05821192 Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma. Status UNKNOWN Phase NA
NCT05820763 Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant Status WITHDRAWN Phase PHASE2
NCT05809011 Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF) Status RECRUITING Phase PHASE2/PHASE3
NCT05804032 Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT05789303 Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Status RECRUITING Phase PHASE2
NCT05773664 Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma Status WITHDRAWN Phase PHASE1
NCT05751044 HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT05745714 HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT05738486 A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05736419 A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) Status RECRUITING Phase PHASE2
NCT05732883 The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia Status RECRUITING Phase PHASE2
NCT05732532 Steroids in Occipital Nerve Block for Treatment of Headache Status COMPLETED Phase PHASE4
NCT05731960 Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia After Cesarean Delivery Status RECRUITING Phase PHASE4
NCT05730036 A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma Status RECRUITING Phase PHASE3
NCT05727163 FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients Status RECRUITING Phase PHASE2
NCT05719701 Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05704049 A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2